Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Conatus Pharmaceuticals Inc | 45,000 | reported | 27 Jun 2019 | tx 15+346,770−186,598 |
| METABASIS THERAPEUTICS INC | 10,000 | reported | 23 Jun 2009 | tx 16+326,473−106,241 |
| GTX INC /DE/ | 3,300 | reported | 20 Jun 2024 | tx 17+926,442−191,169 |
| Dermata Therapeutics, Inc. | 2,500 | reported | 02 Jan 2026 | tx 23+604,811−5,151,662 |
| BIOCEPT INC | 796 | reported | 09 Dec 2021 | tx 37+818,602−150,476 |
| Somaxon Pharmaceuticals, Inc. | 0 | reported | 06 Mar 2013 | tx 65+1,481,193−548,912 |
| CANCERVAX CORP | 0 | reported | 07 Mar 2012 | tx 54+1,174,342−1,063,259 |
| SANTARUS INC | 0 | reported | 02 Jan 2014 | tx 64+740,341−1,118,640 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Dermata Therapeutics, Inc. | 2,500 | 0.00 USD | deriv |
| 23 Jan 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 78,741 | — | |
| 21 Jan 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 78,741 | — | deriv |
| 13 Jan 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | GTX INC /DE/ | 3,300 | 0.00 USD | deriv |
| 23 Feb 2024 | PURCHASE | GTX INC /DE/ | 714 | 9.04 USD | first after silence |
| 23 Feb 2024 | PURCHASE | GTX INC /DE/ | 266 | 9.04 USD | |
| 04 Jan 2024 | GRANT_AWARD | Dermata Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 28 Jun 2023 | GRANT_AWARD | GTX INC /DE/ | 37,500 | 0.00 USD | deriv |
| 06 Oct 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 30,155 | 0.00 USD | |
| 07 Jul 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 26,441 | 0.00 USD | |
| 16 Jun 2022 | GRANT_AWARD | GTX INC /DE/ | 37,500 | 0.00 USD | deriv |
| 07 Apr 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 15,466 | 0.00 USD | |
| 01 Oct 2021 | GIFT | GTX INC /DE/ | 125,000 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 09 Dec 2021 | SALE | BIOCEPT INC | 71 | 4.07 USD | |
| 09 Dec 2021 | SALE | BIOCEPT INC | 11 | 4.07 USD | |
| 09 Dec 2021 | SALE | BIOCEPT INC | 363 | 4.06 USD | |
| 17 Aug 2021 | CONVERSION | Dermata Therapeutics, Inc. | 44,777 | — | |
| 17 Aug 2021 | CONVERSION | Dermata Therapeutics, Inc. | 12,195 | — | |
| 17 Aug 2021 | PURCHASE | Dermata Therapeutics, Inc. | 35,714 | — | |
| 17 Aug 2021 | CONVERSION | Dermata Therapeutics, Inc. | 174,216 | — | |
| 17 Aug 2021 | CONVERSION | Dermata Therapeutics, Inc. | 27,103 | — | |
| 17 Aug 2021 | CONVERSION | Dermata Therapeutics, Inc. | 20,000 | — | |
| 17 Aug 2021 | CONVERSION | Dermata Therapeutics, Inc. | 302,112 | 0.00 USD | deriv |
7 purchases reported after at least 12 months of silence — most recent on 23 Feb 2024.